Skip to main content
The Markets by Proactive
Go to Proactive Australia

Archive

Feedback raise full-year expectations as sales of Bleepa in NHS and veterinary sectors rise

Feedback raise full-year expectations as sales of Bleepa in NHS and veterinary sectors rise

Feedback PLC (AIM:FDBK)'s (Feedback PLC (AIM:FDBK)) Tom Oakley talks to Proactive London about their interim results for the full-year outlook which is expected to be ahead of market expectations.

Revenues in the six months to the end of November were up 9% on the same period of 2020 at £179,000 (2020: £165,000), despite revenues from legacy products such as Cadran and Texrad declining.

Operating expenses increased by 25% in the reporting period to £1.36mln from £1.08mln, primarily due to increased headcount to drive the development and rollout of Bleepa.